Humanisation and pre-clinical validation of a therapeutic anti-cancer antibody [ 2015 - ]

Research Grant

Researchers: Prof Andrew Scott (Principal investigator) ,  Dr Peter Janes ,  Prof Dimitar Nikolov ,  Prof Mark Sleeman

Brief description This grant will develop a novel antibody against a protease expressed on cancer cells. Preclinical studies, and antibody humanisation, will be performed. This project will also provide vital information on optimal therapeutic approaches with the antibody that can be ultimately taken into human trials.

Funding Amount $678,236.00

Funding Scheme Development Grants

Notes Development Grant